Status:
RECRUITING
To Identify Potential New Urine Marker Panel for Cancer Screening
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore...
Detailed Description
Urine tests is a simple, non-invasive approach for cancer detection. One example of such cancer biomarkers are natural polyamines. Recently, there are also other reports on the use of polyamines in di...
Eligibility Criteria
Inclusion
- Adult patients with age \> 18 years old.
- For cancer patients, a histological diagnosis of cancer is available.
- For normal control, there is no diagnosis of cancer in the medical record.
Exclusion
- Patient with recent urinary tract infection within 6 weeks prior to urine collection.
- Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
- Patient refused or unable to provide consent for the study
Key Trial Info
Start Date :
January 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04689802
Start Date
January 20 2021
End Date
March 31 2026
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong